Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats

Alessandro Cataliotti, Jason M. Tonne, Diego Bellavia, Fernando L. Martin, Elise A. Oehler, Gerald E. Harders, Jarryd M. Campbell, Kah-Whye Peng, Stephen J Russell, Lorenzo S. Malatino, John C Jr. Burnett, Yasuhiro H Ikeda

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background- Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results- We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expression. In SHR, a single systemic administration of AAV9 vector allowed long-term cardiac BNP overexpression, resulting in reductions in systolic and diastolic BP for 9 months after injection. Left ventricular (LV) thickness, LV end-systolic dimensions, and LV mass were reduced, whereas ejection fraction was significantly increased, in BNP-treated compared with untreated SHR. Circumferential systolic strain and strain rate of the early phase of diastole were improved in BNP-treated compared with untreated SHR. Noncardiac overexpression of BNP via AAV2 vector was not associated with changes in BP and plasma BNP in SHR. Furthermore, normal Wistar rats injected with AAV9 proBNP vector showed significantly reduced heart weights 4 weeks after injection without BP reduction. Conclusions- AAV9 vector facilitates sustained cardiac proBNP overexpression and improves LV function in hypertensive heart disease. Long-term proBNP delivery improved both systolic and diastolic function. The effects on cardiac structure and function occurred independently of BP-lowering effects in normal Wistar rats.

Original languageEnglish (US)
Pages (from-to)1297-1305
Number of pages9
JournalCirculation
Volume123
Issue number12
DOIs
StatePublished - Mar 29 2011

Fingerprint

Brain Natriuretic Peptide
Inbred SHR Rats
Heart Diseases
Dependovirus
Blood Pressure
Genes
Wistar Rats
Hypertension
Injections
Diastole
Left Ventricular Function
Myocardium
Fibrosis
Heart Failure
Weights and Measures
Serogroup

Keywords

  • cardiac remodeling
  • hypertension
  • natriuretic peptide, brain

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. / Cataliotti, Alessandro; Tonne, Jason M.; Bellavia, Diego; Martin, Fernando L.; Oehler, Elise A.; Harders, Gerald E.; Campbell, Jarryd M.; Peng, Kah-Whye; Russell, Stephen J; Malatino, Lorenzo S.; Burnett, John C Jr.; Ikeda, Yasuhiro H.

In: Circulation, Vol. 123, No. 12, 29.03.2011, p. 1297-1305.

Research output: Contribution to journalArticle

Cataliotti, Alessandro ; Tonne, Jason M. ; Bellavia, Diego ; Martin, Fernando L. ; Oehler, Elise A. ; Harders, Gerald E. ; Campbell, Jarryd M. ; Peng, Kah-Whye ; Russell, Stephen J ; Malatino, Lorenzo S. ; Burnett, John C Jr. ; Ikeda, Yasuhiro H. / Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. In: Circulation. 2011 ; Vol. 123, No. 12. pp. 1297-1305.
@article{ae447b1adfe1419c84cf0b781087108b,
title = "Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats",
abstract = "Background- Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results- We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expression. In SHR, a single systemic administration of AAV9 vector allowed long-term cardiac BNP overexpression, resulting in reductions in systolic and diastolic BP for 9 months after injection. Left ventricular (LV) thickness, LV end-systolic dimensions, and LV mass were reduced, whereas ejection fraction was significantly increased, in BNP-treated compared with untreated SHR. Circumferential systolic strain and strain rate of the early phase of diastole were improved in BNP-treated compared with untreated SHR. Noncardiac overexpression of BNP via AAV2 vector was not associated with changes in BP and plasma BNP in SHR. Furthermore, normal Wistar rats injected with AAV9 proBNP vector showed significantly reduced heart weights 4 weeks after injection without BP reduction. Conclusions- AAV9 vector facilitates sustained cardiac proBNP overexpression and improves LV function in hypertensive heart disease. Long-term proBNP delivery improved both systolic and diastolic function. The effects on cardiac structure and function occurred independently of BP-lowering effects in normal Wistar rats.",
keywords = "cardiac remodeling, hypertension, natriuretic peptide, brain",
author = "Alessandro Cataliotti and Tonne, {Jason M.} and Diego Bellavia and Martin, {Fernando L.} and Oehler, {Elise A.} and Harders, {Gerald E.} and Campbell, {Jarryd M.} and Kah-Whye Peng and Russell, {Stephen J} and Malatino, {Lorenzo S.} and Burnett, {John C Jr.} and Ikeda, {Yasuhiro H}",
year = "2011",
month = "3",
day = "29",
doi = "10.1161/CIRCULATIONAHA.110.981720",
language = "English (US)",
volume = "123",
pages = "1297--1305",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats

AU - Cataliotti, Alessandro

AU - Tonne, Jason M.

AU - Bellavia, Diego

AU - Martin, Fernando L.

AU - Oehler, Elise A.

AU - Harders, Gerald E.

AU - Campbell, Jarryd M.

AU - Peng, Kah-Whye

AU - Russell, Stephen J

AU - Malatino, Lorenzo S.

AU - Burnett, John C Jr.

AU - Ikeda, Yasuhiro H

PY - 2011/3/29

Y1 - 2011/3/29

N2 - Background- Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results- We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expression. In SHR, a single systemic administration of AAV9 vector allowed long-term cardiac BNP overexpression, resulting in reductions in systolic and diastolic BP for 9 months after injection. Left ventricular (LV) thickness, LV end-systolic dimensions, and LV mass were reduced, whereas ejection fraction was significantly increased, in BNP-treated compared with untreated SHR. Circumferential systolic strain and strain rate of the early phase of diastole were improved in BNP-treated compared with untreated SHR. Noncardiac overexpression of BNP via AAV2 vector was not associated with changes in BP and plasma BNP in SHR. Furthermore, normal Wistar rats injected with AAV9 proBNP vector showed significantly reduced heart weights 4 weeks after injection without BP reduction. Conclusions- AAV9 vector facilitates sustained cardiac proBNP overexpression and improves LV function in hypertensive heart disease. Long-term proBNP delivery improved both systolic and diastolic function. The effects on cardiac structure and function occurred independently of BP-lowering effects in normal Wistar rats.

AB - Background- Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results- We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expression. In SHR, a single systemic administration of AAV9 vector allowed long-term cardiac BNP overexpression, resulting in reductions in systolic and diastolic BP for 9 months after injection. Left ventricular (LV) thickness, LV end-systolic dimensions, and LV mass were reduced, whereas ejection fraction was significantly increased, in BNP-treated compared with untreated SHR. Circumferential systolic strain and strain rate of the early phase of diastole were improved in BNP-treated compared with untreated SHR. Noncardiac overexpression of BNP via AAV2 vector was not associated with changes in BP and plasma BNP in SHR. Furthermore, normal Wistar rats injected with AAV9 proBNP vector showed significantly reduced heart weights 4 weeks after injection without BP reduction. Conclusions- AAV9 vector facilitates sustained cardiac proBNP overexpression and improves LV function in hypertensive heart disease. Long-term proBNP delivery improved both systolic and diastolic function. The effects on cardiac structure and function occurred independently of BP-lowering effects in normal Wistar rats.

KW - cardiac remodeling

KW - hypertension

KW - natriuretic peptide, brain

UR - http://www.scopus.com/inward/record.url?scp=79954628213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954628213&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.110.981720

DO - 10.1161/CIRCULATIONAHA.110.981720

M3 - Article

C2 - 21403100

AN - SCOPUS:79954628213

VL - 123

SP - 1297

EP - 1305

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -